Ganglioglioma pathophysiology: Difference between revisions

Jump to navigation Jump to search
Sujit Routray (talk | contribs)
Sujit Routray (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Ganglioglioma arises from neuronal glial cells, which are cells of the central nervous system. On gross pathology, ganglioglioma varies from partially cystic mass with a mural nodule to a solid mass expanding the overlying [[gyrus]]. On microscopic pathology, it is composed of [[ganglion cells]] and neoplastic glial cells. Markers involved in the pathogenesis of ganglioglioma include synaptophysin, neuronal specific enolase, ''GFAP''


==Pathophysiology==
==Pathophysiology==
Line 15: Line 17:
**[[Third ventricle]]
**[[Third ventricle]]
**[[Spinal cord]].  
**[[Spinal cord]].  
*Their appearance is variable: from a ''partially cystic mass'' with an mural nodule (~45% of cases) to a ''solid mass'' expanding the overlying gyrus.
*Their appearance is variable: from a ''partially cystic mass'' with an mural nodule (~45% of cases) to a ''solid mass'' expanding the overlying gyrus.  


===Microscopic Pathology===
===Microscopic Pathology===

Revision as of 17:44, 4 September 2015

Ganglioglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Ganglioglioma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ganglioglioma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ganglioglioma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onGanglioglioma pathophysiology

CDC on Ganglioglioma pathophysiology

Ganglioglioma pathophysiology in the news

on Ganglioglioma pathophysiology

Directions to Hospitals Treating Ganglioglioma

Risk calculators and risk factors for Ganglioglioma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Ganglioglioma arises from neuronal glial cells, which are cells of the central nervous system. On gross pathology, ganglioglioma varies from partially cystic mass with a mural nodule to a solid mass expanding the overlying gyrus. On microscopic pathology, it is composed of ganglion cells and neoplastic glial cells. Markers involved in the pathogenesis of ganglioglioma include synaptophysin, neuronal specific enolase, GFAP


Pathophysiology

Gross Pathology

Microscopic Pathology

Gangliogliomas are composed of two cell populations:[1]

  • Ganglion cells (large mature neuronal elements): ganglio-
  • Neoplastic glial elements (primarily astrocytic): -glioma

It is the grade of the glial component that determines biological behaviour. Dedifferentiation into high grade tumours does occasionally occur, and it is usually the glial component (into a glioblastoma multiforme). Only rarely is it the neuronal component (into a neuroblastoma).

Markers

Neuronal origin is demonstrated by positivity to neuronal markers:[1]

  • Synaptophysin
  • Neuronal specific enolase
  • GFAP

References

  1. 1.0 1.1 1.2 Pathophysiology of ganglioglioma. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/ganglioglioma


Template:WikiDoc Sources